Cell-free biocatalysis for co-production of nicotinamide mononucleotide and ethanol from Saccharomyces cerevisiae and recombinant Escherichia coli

Cell-free enzyme systems have emerged as a promising approach for producing various biometabolites, offering several advantages over traditional whole-cell systems. This study presents an approach to producing nicotinamide mononucleotide (NMN) by combining a Saccharomyces cerevisiae cell-free enzyme with a recombinant Escherichia coli cell-free enzyme. The system leverages the ATP generated by yeast during ethanol fermentation to produce NMN in the presence of nicotinamide (NAM) as a substrate. The optimal cell-free enzyme concentration and substrate concentration were investigated to maximize NMN production. The results showed that combined cell-free enzymes led to increased NMN and ethanol yields, with a maximum production of 1.5 mM NMN (2.7-fold) and ethanol production of 0.45 g/L achieved (1.6-fold) compared to individual cell-free enzymes. Furthermore, the study demonstrated that the protein concentration affected NMN production, with optimal production achieved at 5 g/L. This study demonstrates the potential of integrating multiple metabolic pathways in a single cell-free system, paving the way for the development of more efficient and sustainable bioproduction processes.